Enalaprilat and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Enalaprilat (enalaprilat), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Lasix, and have Rheumatoid arthritis.

The study is created by eHealthMe based on reports of 449 people who have side effects when taking Enalaprilat from the FDA, and is updated regularly.

What is Enalaprilat?

Enalaprilat has active ingredients of enalaprilat. It is often used in high blood pressure. eHealthMe is studying from 538 Enalaprilat users. Check the latest studies of Enalaprilat.

On May, 14, 2026

449 people reported to have side effects when taking Enalaprilat.
Among them, 17 people (3.79%) died.

Among these 17 people:

How long have people been on Enalaprilat when they died? *

What is the gender of people who died when taking Enalaprilat? *

female: 43.75 %
male: 56.25 %

What is the age of people who died when taking Enalaprilat? *

What are other drugs people take besides Enalaprilat? *

What are other side effects people have before they died? *

Acute Kidney Failure: 2 people, 11.76%
Pain: 2 people, 11.76%
Injury: 2 people, 11.76%
Hemiplegia (paralysis of one side of the body): 1 person, 5.88%
Haemorrhagic Stroke (stroke caused by the rupture of a blood vessel in the brain): 1 person, 5.88%
Haemoglobin Decreased: 1 person, 5.88%
General Physical Health Deterioration (weak health status): 1 person, 5.88%
Gastrointestinal Perforation (hole in the digestive tract): 1 person, 5.88%
Fear: 1 person, 5.88%
Emotional Distress: 1 person, 5.88%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.76%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 5.88%
Renal Cell Carcinoma (a kidney cancer): 1 person, 5.88%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 5.88%
Premature Baby: 1 person, 5.88%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 1 person, 5.88%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 5.88%
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract): 1 person, 5.88%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 5.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Enalaprilat:

Enalaprilat (538 reports)

Expand to all the drugs that have ingredients of enalaprilat:

Death and drugs with ingredients of enalaprilat (49 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Enalaprilat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,121 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enalaprilat (the active ingredients of Enalaprilat) and Enalaprilat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.